|
DE102006024528A1
|
|
New formulation of a cytostatic, especially cis-platin, oriented on tumor physiology
|
|
CA2607694A1
|
|
Method for producing albumin conjugates comprising an x-ray contrast medium as the active substance
|
|
US2008108708A1
|
|
Method for producing albumin conjugates containing gyrase inhibitors
|
|
CA2589455A1
|
|
Process for producing albumin conjugates with non-steroidal antirheumatic agents (nsar)
|
|
US2008051376A1
|
|
Method for Producing Albumin-Corticoid Conjugates
|
|
DE102005019104A1
|
|
New conjugate of fluorescent dye bonded directly to protein, useful for intraoperative representation of tumors, inflammation and lymph nodes
|
|
WO2005094895A1
|
|
Production and use of the methotrexate-albumin conjugate as an immunosuppressive agent in gvhd
|
